Fluticasone Propionate Aerosol, Metered
Product Images NDC 50090-6058

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 50090-6058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)

FDA Label Image

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)

FDA Label Image

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)

This is a chart showing the percent change from baseline in FEV (forced expiratory volume) for different doses (0mg for placebo, 83mg, 220mg, and 440mg twice daily) of Fluticasone Propionate HFA over a 12 week period.*

FDA Label Image

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)

This appears to be a graphical representation of the percentage of subjects with an increase in dose of Fluticasone Propionate HFA. It shows that on the lower dose (440 meg twice daily), 38% of subjects experienced an increase in dose, while on the higher dose (880 meg twice daily), only 5% of subjects required an increase in dose. There is also mention of a reduction in dose and a placebo group, but it is not clear from the text what these refer to.*

FDA Label Image

Figure A (Fluticasonepropionatehfa Spl Graphic 05)

This text describes a metal canister with a dark orange plastic actuator and mouthpiece. It also mentions a peach cap. More information is needed to determine the purpose or use of this object.*

FDA Label Image

Figure B (Fluticasonepropionatehfa Spl Graphic 06)

FDA Label Image

Figure C (Fluticasonepropionatehfa Spl Graphic 07)

FDA Label Image

Figure D (Fluticasonepropionatehfa Spl Graphic 08)

FDA Label Image

Figure E (Fluticasonepropionatehfa Spl Graphic 09)

The text describes a mouthpiece in a downward position with a dark orange color.*

FDA Label Image

Figure F (Fluticasonepropionatehfa Spl Graphic 10)

This text is readable. It appears to be a instruction to exhale or breathe out all the air one possibly can.*

FDA Label Image

Figure G (Fluticasonepropionatehfa Spl Graphic 11)

FDA Label Image

Figure H (Fluticasonepropionatehfa Spl Graphic 12)

FDA Label Image

Figure I (Fluticasonepropionatehfa Spl Graphic 13)

FDA Label Image

Figure J (Fluticasonepropionatehfa Spl Graphic 14)

FDA Label Image

Label Image (Lbl500906058)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.